ArticleTransfusion2020

Isoagglutinin-reduced immunoglobulin retains efficacy in mouse models of immune thrombocytopenia and rheumatoid arthritis and is less likely to cause intravenous immunoglobulin-associated hemolysis.

Selena Y Cen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.